| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/26/2011 | US7985834 Compositions and methods for increasing bone mineralization |
| 07/26/2011 | US7985833 Collectin |
| 07/26/2011 | US7985832 Antimicrobial cathelicidin peptides |
| 07/26/2011 | US7985736 Therapeutic mixture comprising voltage gated calcium channel modulator for use in treatment and prevention of infertility, cancer, diabetes and behavioral disorders |
| 07/26/2011 | US7985732 Unitary combination of FSH and hCG |
| 07/26/2011 | US7985729 Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| 07/26/2011 | US7985728 Sustained release of Apo A-I mimetic peptides and methods of treatment |
| 07/26/2011 | US7985726 ψεRACK peptide composition and method for protection against tissue damage due to ischemia |
| 07/26/2011 | US7985591 Dirofilaria cuticle protein for use in identifying modulators and preparing vaccines for prevention and treatment worm infection |
| 07/26/2011 | US7985583 Chlamydomonas intraflagellar transport 88 (IFT-88) |
| 07/26/2011 | US7985564 Expression systems with sec-system secretion |
| 07/26/2011 | US7985563 HIFαprolyl hydroxylation assay |
| 07/26/2011 | US7985559 Methods of selecting epidermal growth factor receptor (EGFR) binding agents |
| 07/26/2011 | US7985411 Activatable recombinant neurotoxins |
| 07/26/2011 | CA2633354C Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy |
| 07/26/2011 | CA2569767C Plastid transit peptides |
| 07/26/2011 | CA2461571C Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 07/26/2011 | CA2441225C A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 07/26/2011 | CA2438851C Interleukin-18 mutants, their production and use |
| 07/26/2011 | CA2411249C Gasc1 gene |
| 07/26/2011 | CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 07/26/2011 | CA2352467C Apoptosis-inducing factor |
| 07/26/2011 | CA2334315C Compounds with growth hormone releasing properties |
| 07/26/2011 | CA2299677C Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 07/26/2011 | CA2289912C Human receptor proteins; related reagents and methods |
| 07/26/2011 | CA2222757C Modified/chimeric superantigens and their use |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/26/2011 | CA2213340C Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
| 07/21/2011 | WO2011088409A1 Fusion proteins for delivery of erythropoietin to the cns |
| 07/21/2011 | WO2011088244A1 Therapeutic apyrase constructs, apyrase agents, and production methods |
| 07/21/2011 | WO2011087810A1 Modified porcine somatotropin polypeptides and their uses |
| 07/21/2011 | WO2011087808A1 Modified bovine somatotropin polypeptides and their uses |
| 07/21/2011 | WO2011087803A1 Assay for monitoring parathyroid hormone (pth) variants by tandem mass spectrometry |
| 07/21/2011 | WO2011087768A1 Bmp-7 variants with reduced immunogenicity |
| 07/21/2011 | WO2011087672A1 Oxyntomodulin peptide analogue |
| 07/21/2011 | WO2011087671A1 Oxyntomodulin peptide analogue |
| 07/21/2011 | WO2011086589A1 Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field |
| 07/21/2011 | WO2011086509A1 Methods of producing adenovirus vectors and viral preparations generated thereby |
| 07/21/2011 | WO2011086322A1 Proteins interacting with gcp3 and uses thereof |
| 07/21/2011 | WO2011086293A1 Sulfatase selectively modifying glycosaminoglycans |
| 07/21/2011 | WO2011086197A1 Purification of blood coagulation factors |
| 07/21/2011 | WO2011086172A1 Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (ibd) and irritable bowel syndrome (ibs) |
| 07/21/2011 | WO2011086139A1 Bacterial host strain expressing recombinant dsbc and having reduced tsp activity |
| 07/21/2011 | WO2011086136A1 Bacterial host strain comprising a mutant spr gene and having reduced tsp activity |
| 07/21/2011 | WO2011085920A1 Collagen fiber constructs for replacing cruciate ligaments |
| 07/21/2011 | WO2011085783A1 Variants of the group-5 allergens of the poaceae with reduced allergenicity by mutagenesis of proline residues |
| 07/21/2011 | WO2011085782A1 Variants of the group-6 allergens of the poaceae with reduced allergenicity by mutagenesis of proline residues |
| 07/21/2011 | WO2011085704A1 Chimeric human beta defensins |
| 07/21/2011 | WO2011085598A1 Manufacture process for preparing high purity apoa-i from precipitate of plasma fraction iv. |
| 07/21/2011 | WO2011085423A1 Cyclic peptides for the regulation of vectorial ion channels |
| 07/21/2011 | WO2011065867A3 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 07/21/2011 | WO2011064664A3 T cell receptors specific for immunodominant ctl epitopes of hcv |
| 07/21/2011 | WO2011026015A3 Stabilized melanocortin ligands |
| 07/21/2011 | WO2011016632A3 Gene coding for an auxin receptor protein derived from the rice plant, and applications therefor |
| 07/21/2011 | WO2011006133A3 Bioengineered silk protein-based nucleic acid delivery systems |
| 07/21/2011 | WO2010151671A3 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2 |
| 07/21/2011 | WO2010135749A9 Herpes simplex virus type2: compositions and methods for eliciting an immune response |
| 07/21/2011 | US20110179528 Novel genes involved in biosynthesis |
| 07/21/2011 | US20110179522 Defensin polynucleotides and methods of use |
| 07/21/2011 | US20110178275 Industrial plant-based production of animal-free recombinant proteins in defined environment |
| 07/21/2011 | US20110178274 Canine transient receptor potential v2 (ctrpv2) and methods of screening for trpv2 channel modulators |
| 07/21/2011 | US20110178272 Isolated bitter taste receptor polypeptides |
| 07/21/2011 | US20110178271 Sterilization method |
| 07/21/2011 | US20110178270 T-cell death-inducing epitopes |
| 07/21/2011 | US20110178160 Inhibition of Interaction of PSD93 and PSDS95 with nNOS and NMDA Receptors |
| 07/21/2011 | US20110178031 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid |
| 07/21/2011 | US20110178029 Modified Human Apolipoprotein A-1 and Their Uses |
| 07/21/2011 | US20110178026 Ricin-like toxins for treatment of cancer |
| 07/21/2011 | US20110178016 Pulse parathyroid hormone for treatment of the hematopoietic syndrome, stromal cell loss, and vascular injury resulting from acute exposure to lethal radiation |
| 07/21/2011 | US20110178011 Polysaccharide/BMP complexes which are soluble at physiological pH |
| 07/21/2011 | US20110178010 Use of peptides for promoting wound healing |
| 07/21/2011 | US20110178006 Method for administering glp-1 molecules |
| 07/21/2011 | US20110178004 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 07/21/2011 | US20110178000 Apoptotically Active Peptides |
| 07/21/2011 | US20110177998 Bioactive peptides and methods of using same |
| 07/21/2011 | US20110177997 Cross-Beta Silk Genes |
| 07/21/2011 | US20110177972 Compositions and methods for the treatment of immune related diseases |
| 07/21/2011 | US20110177611 Ligand binding domains of nuclear receptors in controllable form and methods involving the same |
| 07/21/2011 | US20110177599 Delivery of nucleic acids across membranes |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177589 Novel human polyomavirus |
| 07/21/2011 | US20110177565 Isolated polypeptide for increasing activity of polysaccharide hydrolase and methods of use |
| 07/21/2011 | US20110177556 Nucleic Acids Encoding Chimeric CD154 Polypeptides |
| 07/21/2011 | US20110177554 Secreted frizzled related protein, sfrp, fragments and methods of use thereof |
| 07/21/2011 | US20110177545 G-proteins |
| 07/21/2011 | US20110177524 Recombinant Fibrinogen |
| 07/21/2011 | US20110177522 Methods for Producing Olfactory GPCRs |
| 07/21/2011 | US20110177501 Biosensor for detection and visualisation of single-stranded dna |
| 07/21/2011 | US20110177498 Base-detecting pore |
| 07/21/2011 | US20110177316 Lyzable molded parts |
| 07/21/2011 | US20110177154 Tubular nanostructure targeted to cell membrane |
| 07/21/2011 | US20110177151 Implantable material and a method for the preparation thereof |
| 07/21/2011 | US20110177124 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/21/2011 | US20110177117 Chimeric respiratory syncytial virus polypeptide antigens |
| 07/21/2011 | US20110177110 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 07/21/2011 | US20110177109 Antigenic tau peptides and uses thereof |
| 07/21/2011 | US20110177093 Use of bcma as an immunoregulatory agent |
| 07/21/2011 | US20110177089 Apoptosis inducer |
| 07/21/2011 | US20110177085 Bitter Taste Receptors |
| 07/21/2011 | US20110177083 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |